Brezniceanu, M.L., Lau, C.J., Godin, N., Chenier, I., Duclos, A., Ethier, J., Filep, J.G., Ingelfinger, J.R., Zhang, S.L., Chan, J.S., 2010. Reactive oxygen species promote caspase-12 expression and tubular apoptosis in diabetic nephropathy. J. Am. Soc. Nephrol. 21, 943-954.
|
Cai, Y., Pi, W., Sivaprakasam, S., Zhu, X., Zhang, M., Chen, J., Makala, L., Lu, C., Wu, J., Teng, Y., et al., 2015. UFBP1, a key component of the Ufm1 conjugation system, is essential for Ufmylation-mediated regulation of erythroid development. PLoS Genet. 11, e1005643.
|
Cai, Y., Zhu, G., Liu, S., Pan, Z., Quintero, M., Poole, C.J., Lu, C., Zhu, H., Islam, B., Riggelen, J.V., et al., 2019. Indispensable role of the Ubiquitin-fold modifier 1-specific E3 ligase in maintaining intestinal homeostasis and controlling gut inflammation. Cell Discov. 5, 7.
|
Cappadocia, L., Lima, C.D., 2018. Ubiquitin-like protein conjugation:structures, chemistry, and mechanism. Chem. Rev. 118, 889-918.
|
Duan, R., Shi, Y., Yu, L., Zhang, G., Li, J., Lin, Y., Guo, J., Wang, J., Shen, L., Jiang, H., et al., 2016. UBA5 mutations cause a new form of autosomal recessive cerebellar ataxia. PLoS One 11, e0149039.
|
Gowda, S., Desai, P.B., Kulkarni, S.S., Hull, V.V., Math, A.A., Vernekar, S.N., 2010. Markers of renal function tests. N. Am. J. Med. Sci. 2, 170-173.
|
Komatsu, M., Chiba, T., Tatsumi, K., Iemura, S., Tanida, I., Okazaki, N., Ueno, T., Kominami, E., Natsume, T., Tanaka, K., 2004. A novel protein-conjugating system for Ufm1, a ubiquitin-fold modifier. EMBO J. 23, 1977-1986.
|
Lees, G.E., 2004. Early diagnosis of renal disease and renal failure. Vet. Clin. North Am. Small Anim. Pract. 34, 867-885.
|
Li, J., Yue, G., Ma, W., Zhang, A., Zou, J., Cai, Y., Tang, X., Wang, J., Liu, J., Li, H., et al., 2018. Ufm1-specific ligase Ufl1 regulates endoplasmic reticulum homeostasis and protects against heart failure. Circ. Heart Fail. 11, e004917.
|
Liu, J., Guan, D., Dong, M., Yang, J., Wei, H., Liang, Q., Song, L., Xu, L., Bai, J., Liu, C., Mao, J., Zhang, Q., Zhou, J., Wu, X., Wang, M., Cong, Y.S., 2020. UFMylation maintains tumour suppressor p53 stability by antagonizing its ubiquitination. Nat. Cell Biol. 22, 1056-1063.
|
Liu, Y., 2011. Cellular and molecular mechanisms of renal fibrosis. Nat. Rev. Nephrol. 7, 684-696.
|
Low, K.J., Baptista, J., Babiker, M., Caswell, R., King, C., Ellard, S., Scurr, I., 2019.
|
Hemizygous UBA5 missense mutation unmasks recessive disorder in a patient with infantile-onset encephalopathy, acquired microcephaly, small cerebellum, movement disorder and severe neurodevelopmental delay. Eur. J. Med. Genet. 62, 97-102.
|
Lusco, M.A., Fogo, A.B., Najafian, B., Alpers, C.E., 2016. AJKD atlas of renal pathology:tubular atrophy. Am. J. Kidney Dis. 67, e23-e24.
|
Miller, C., Cai, Y., Patton, T., Graves, S.H., Li, H., Sabbatini, M.E., 2017. RCAD/BiP pathway is necessary for the proper synthesis of digestive enzymes and secretory function of the exocrine pancreas. Am. J. Physiol. Gastrointest. Liver Physiol. 312, G314-G326.
|
Muona, M., Ishimura, R., Laari, A., Ichimura, Y., Linnankivi, T., Keski-Filppula, R., Herva, R., Rantala, H., Paetau, A., Poyhonen, M., et al., 2016. Biallelic variants in UBA5 link dysfunctional UFM1 ubiquitin-like modifier pathway to severe infantileonset encephalopathy. Am. J. Hum. Genet. 99, 683-694.
|
Nahorski, M.S., Maddirevula, S., Ishimura, R., Alsahli, S., Brady, A.F., Begemann, A., Mizushima, T., Guzman-Vega, F.J., Obata, M., Ichimura, Y., et al., 2018. Biallelic UFM1 and UFC1 mutations expand the essential role of UFMylation in brain development. Brain 141, 1934-1945.
|
Neziri, D., Pajenda, S., Amuge, R., Ilhan, A., Wewalka, M., Hormann, G., Zauner, C., Wagner, L., 2016. DDRGK1 in urine indicative of tubular cell injury in intensive care patients with serious infections. J. Nephropathol. 5, 65-71.
|
Schelling, J.R., 2016. Tubular atrophy in the pathogenesis of chronic kidney disease progression. Pediatr. Nephrol. 31, 693-706.
|
Seki, M., Nakayama, M., Sakoh, T., Yoshitomi, R., Fukui, A., Katafuchi, E., Tsuda, S., Nakano, T., Tsuruya, K., Kitazono, T., 2019. Blood urea nitrogen is independently associated with renal outcomes in Japanese patients with stage 3-5 chronic kidney disease:a prospective observational study. BMC Nephrol. 20, 115.
|
Tatsumi, K., Sou, Y.S., Tada, N., Nakamura, E., Iemura, S., Natsume, T., Kang, S.H., Chung, C.H., Kasahara, M., Kominami, E., et al., 2010. A novel type of E3 ligase for the Ufm1 conjugation system. J. Biol. Chem. 285, 5417-5427.
|
Tatsumi, K., Yamamoto-Mukai, H., Shimizu, R., Waguri, S., Sou, Y.S., Sakamoto, A., Taya, C., Shitara, H., Hara, T., Chung, C.H., et al., 2011. The Ufm1-activating enzyme Uba5 is indispensable for erythroid differentiation in mice. Nat. Commun. 2, 181.
|
Watanabe, M., Nakatsuka, A., Murakami, K., Inoue, K., Terami, T., Higuchi, C., Katayama, A., Teshigawara, S., Eguchi, J., Ogawa, D., et al., 2014. Pemt deficiency ameliorates endoplasmic reticulum stress in diabetic nephropathy. PLoS One 9, e92647.
|
Wu, J., Lei, G., Mei, M., Tang, Y., Li, H., 2010. A novel C53/LZAP-interacting protein regulates stability of C53/LZAP and DDRGK domain-containing Protein 1(DDRGK1) and modulates NF-kappaB signaling. J. Biol. Chem. 285, 15126-15136.
|
Yoo, H.M., Kang, S.H., Kim, J.Y., Lee, J.E., Seong, M.W., Lee, S.W., Ka, S.H., Sou, Y.S., Komatsu, M., Tanaka, K., et al., 2014. Modification of ASC1 by UFM1 is crucial for ERalpha transactivation and breast cancer development. Mol. Cell 56, 261-274.
|
Zhang, M., Zhu, X., Zhang, Y., Cai, Y., Chen, J., Sivaprakasam, S., Gurav, A., Pi, W., Makala, L., Wu, J., et al., 2015. RCAD/Ufl1, a Ufm1 E3 ligase, is essential for hematopoietic stem cell function and murine hematopoiesis. Cell Death Differ. 22, 1922-1934.
|